1-6 of 6
Ahmed Alaskar, MD
Close
Sort by
Journal Articles

A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients

Hani Al Hashmi, MD, Deia Alawami, MD, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS, Nawal F Alshehry, MD, Hazza A. Alzahrani, MD, Abdul Rehman Z Zaidi, MBBS, Ahmed Al Sagheir, MD, Osamah Khojah, MD, Ahmed Alaskar, MD FRCPC, Noura AlMozain, MD, Rehab Al-Ansari, MD, Mona Alfaraj, MD, Ghada ElGohary, MDPhDMBBS, Afra Dayel, MD, Ahmed Bahrani, MD, Arwa Nabhan Abdulhamid, MD, Hind Alhumaidan, MD, Mohammed Albalawi, MD, Alia AlFraedhi, MD, Jawaher Al-Otaibi, MD, Rania Abdallah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-138496
Published: 2020
Journal Articles

Favourable Outcome of Non Myeloablative Allogeneic HSCT in Adult Patients with Severe Sickle Cell Disease: A Single Center Experience of 110 Patients

Mohsen Alzahrani, Bader Alahmari, Ahmed Alaskar, MD FRCPC, Ayman Hejazi, Giamal Edin Gmati, MD, Khadega A. Abuelgasim, Hind Salama, Abdulrahman Raiza, Abdulrahman Alghamdi, Walid Mashaqbeh, Heba Alshobaki, Tahani Alanazy, Maybelle Balili, Muhammad Qureshi, Mazin Ahmed, Husam Mazin Alsadi, MD, Moussab Damlaj
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-139348
Published: 2020
Journal Articles

Clinicopathological Description from the Largest Series of Patients with the Novel Pro106Leu MPL gene Mutation Associated with Hereditary Thrombocythemia

Musa Alzahrani, MBBS, MHSc, Areej Al Mugairi, Saeed Al Turki, Waleed Al Rajban, Fatimah Alshalati, Khadega A. Abuelgasim, Bader Alahmari, Thamer Al Bogami, Osama Ali, MD, Fahad Almodaihsh, Maram Alotaibi, Aamer Aleem, MBBS, FRCP, FRCPath, Ahmed Alaskar, MD FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-136077
Published: 2020
Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5549.
https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549
Published: 2017
Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 2799.
https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799
Published: 2017
Journal Articles

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Ahmed Alaskar, MD, Ahmad Al Ameer, Gasmelseed Ahmed, MD, Ayman Alhejazi, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Mushtaq Rather, MD, Mohsen Al Zahrani, MD
Journal: Blood
Blood (2014) 124 (21): 5477.
https://doi.org/10.1182/blood.V124.21.5477.5477
Published: 2014